Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial.
Anand SrinivasanPinaki DuttaDipika BansalAmitava ChakrabartiAnil Kumar BhansaliDebasish HotaPublished in: Journal of diabetes (2021)
Low-dose naltrexone exhibited similar efficacy and a superior safety profile compared with amitriptyline in painful diabetic neuropathy.